Načítá se...
Chimeric antigen receptor T-cell therapies for multiple myeloma
Multiple myeloma (MM) is a nearly always incurable malignancy of plasma cells, so new approaches to treatment are needed. T-cell therapies are a promising approach for treating MM, with a mechanism of action different than those of standard MM treatments. Chimeric antigen receptors (CARs) are fusion...
Uloženo v:
| Vydáno v: | Blood |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
American Society of Hematology
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5731088/ https://ncbi.nlm.nih.gov/pubmed/28928126 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2017-06-793869 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|